Financial Ratios Ovoca Bio plc Euronext Dublin

Stocks

OVXA

IE0006649010

Specialty Mining & Metals

End-of-day quote Euronext Dublin Other stock markets 05/02/2024			5-day change	1st Jan Change
0.0100 ^EUR	-.--%		-.--%	-

06-29	EARNINGS AND TRADING: Cloudified to acquire PowerPlay for GBP6 million	AN
06-29	Talisman Metals PLC Auditor Raises 'Going Concern' Doubt	CI

486a026dd045339bcd0f.c9adMaS3vEsdanzltWetf1L0y7sHUgwFZAHypz08pBw.JbWpB-Hi0wAwL0SshgPXFiqh-NU_KzVuE0ickw1zlV4dg6pw0IT-ckklSA

Published financial data: OVOCA BIO PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Selling General & Admin Expenses, Total	6.1M	5.42M	1.87M	658K	1.25M
R&D Expenses	-	-	-	-	-
Depreciation & Amortization - (IS)	-	-	-	-	-
Other Operating Expenses	-236K	-1.46M	-1.02M	-409K	-
Other Operating Expenses, Total	5.86M	3.97M	849K	249K	1.25M
Operating Income	-5.86M	-3.97M	-849K	-249K	-1.25M
Interest Expense, Total	-21K	-39K	-5K	-	-6K
Interest And Investment Income	104K	4K	-	-	-
Net Interest Expenses	83K	-35K	-5K	-	-6K
Currency Exchange Gains (Loss)	530K	-1.28M	46K	246K	-87K
EBT, Excl. Unusual Items	-5.25M	-5.28M	-808K	-3K	-1.34M
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-19K	-	-	-
Gain (Loss) On Sale Of Assets	-	-313K	-	-	-
Asset Writedown	-	-	-4.3M	-	-
EBT, Incl. Unusual Items	-5.25M	-5.61M	-5.1M	-3K	-1.34M
Earnings From Continuing Operations	-5.25M	-5.61M	-5.1M	-3K	-1.34M
Earnings Of Discontinued Operations	-228K	-	402K	-743K	5M
Net Income to Company	-5.48M	-5.61M	-4.7M	-746K	3.66M
Minority Interest	-	-	-	-	-
Net Income - (IS)	-5.48M	-5.61M	-4.7M	-746K	3.66M
Net Income to Common Incl Extra Items	-5.48M	-5.61M	-4.7M	-746K	3.66M
Net Income to Common Excl. Extra Items	-5.25M	-5.61M	-5.1M	-3K	-1.34M
Per Share Items
Net EPS - Basic	-0.2	-0.21	-0.17	-0.03	0.12
Basic EPS - Continuing Operations	-0.19	-0.21	-0.19	-0	-0.05
Basic Weighted Average Shares Outstanding	27.19M	27.19M	27.19M	27.19M	29.49M
Net EPS - Diluted	-0.2	-0.21	-0.17	-0.03	0.12
Diluted EPS - Continuing Operations	-0.19	-0.21	-0.19	-0	-0.05
Diluted Weighted Average Shares Outstanding	27.19M	27.19M	27.19M	27.19M	29.49M
Normalized Basic EPS	-0.12	-0.12	-0.02	-0	-0.03
Normalized Diluted EPS	-0.12	-0.12	-0.02	-0	-0.03
Supplemental Items
EBITDA	-5.78M	-3.62M	-549K	51K	-
EBITA	-5.78M	-3.62M	-549K	-249K	-1.25M
EBIT	-5.86M	-3.97M	-849K	-249K	-1.25M
EBITDAR	-5.72M	-3.6M	-	-	-
Normalized Net Income	-3.28M	-3.3M	-505K	-1.88K	-839K
Supplemental Operating Expense Items
General and Administrative Expenses	6.04M	5.41M	1.87M	658K	1.2M
Research And Development Expense From Footnotes	3.55M	2.46M	419K	-	-
Net Rental Expense, Total	56K	15K	-	-	-
Stock-Based Comp., G&A Exp. (Total)	12K	4K	-	-	-
Total Stock-Based Compensation	12K	4K	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	6.59M	3.7M	3.34M	2.51M	2M
Total Cash And Short Term Investments	6.59M	3.7M	3.34M	2.51M	2M
Other Receivables	334K	1.23M	121K	58K	70K
Total Receivables	334K	1.23M	121K	58K	70K
Inventory	94K	43K	-	-	-
Other Current Assets, Total	-	-	10K	90K	-
Total Current Assets	7.02M	4.98M	3.47M	2.65M	2.08M
Gross Property Plant And Equipment	76K	51K	51K	-	-
Accumulated Depreciation	-58K	-51K	-51K	-	-
Net Property Plant And Equipment	18K	0	0	-	-
Long-term Investments	1.95M	-	-	-	-
Goodwill	3.99M	4.24M	-	-	-
Other Intangibles, Total	1.03M	189K	0	-	-
Deferred Charges Long-Term	750K	-	-	-	-
Total Assets	14.77M	9.4M	3.47M	2.65M	2.08M
Liabilities
Accounts Payable, Total	373K	1.17M	301K	146K	381K
Accrued Expenses, Total	181K	102K	68K	63K	-
Short-term Borrowings	-	-	-	-	-
Current Income Taxes Payable	-	113K	-	-	-
Other Current Liabilities	787K	382K	598K	385K	914K
Total Current Liabilities	1.34M	1.77M	967K	594K	1.3M
Total Liabilities	1.34M	1.77M	967K	594K	1.3M
Common Stock, Total	11.06M	11.06M	11.06M	11.06M	11.06M
Additional Paid In Capital	-	-	-	-	13.55M
Retained Earnings	-2.44M	-9.73M	-14.44M	-15.8M	-30.75M
Treasury Stock	-547K	-547K	-547K	-	-
Comprehensive Income and Other	5.36M	6.86M	6.43M	6.8M	6.92M
Total Common Equity	13.43M	7.64M	2.5M	2.06M	780K
Minority Interest	-	-	-	-	-
Total Equity	13.43M	7.64M	2.5M	2.06M	780K
Total Liabilities And Equity	14.77M	9.4M	3.47M	2.65M	2.08M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	27.19M	27.19M	27.19M	29.49M	29.49M
ECS Total Common Shares Outstanding	27.19M	27.19M	27.19M	29.49M	29.49M
Book Value / Share	0.49	0.28	0.09	0.07	0.03
Tangible Book Value	8.4M	3.21M	2.5M	2.06M	780K
Tangible Book Value Per Share	0.31	0.12	0.09	0.07	0.03
Total Debt	0	0	0	0	0
Net Debt	-6.59M	-3.7M	-3.34M	-2.51M	-2M
Debt Equivalent Oper. Leases	448K	120K	-	-	-
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	3
Inventories - Finished Goods, Total	94K	43K	-	-	-
Land - (BS)	-	-	-	-	-
Machinery, Total	76K	51K	51K	-	-
Full Time Employees	10	5	5	1	1

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-5.48M	-5.61M	-4.7M	-746K	3.66M
Depreciation & Amortization - CF	4K	6K	-	-	-
Amortization of Goodwill and Intangible Assets - (CF)	80K	344K	300K	-	-
Depreciation & Amortization, Total	84K	350K	300K	-	-
Amortization of Deferred Charges, Total - (CF)	-	181K	-	-	-
(Gain) Loss From Sale Of Asset	-	313K	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	19K	-	-	-
Asset Writedown & Restructuring Costs	-	-	4.3M	-	-
Stock-Based Compensation (CF)	12K	4K	-	-	-
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	-104K	-	-	-	-16.52M
Change In Accounts Receivable	77K	-899K	1.1M	63K	-12K
Change In Inventories	175K	51K	43K	-	-
Change In Accounts Payable	855K	429K	76K	-160K	927K
Change in Other Net Operating Assets	-	-	-	-293K	-136K
Cash from Operations	-4.38M	-5.16M	1.12M	-1.14M	-12.08M
Capital Expenditure	-14K	-	-	-	-
Sale of Property, Plant, and Equipment	-	1.2M	-	-	-
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-157K	-42K	-49K	-	13.55M
Investment in Marketable and Equity Securities, Total	-	347K	-	-	-
Other Investing Activities, Total	104K	-	-	-	-
Cash from Investing	-67K	1.51M	-49K	-	13.55M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	900K	40K	-	-
Total Debt Issued	-	900K	40K	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-919K	-	-
Total Debt Repaid	-	-	-919K	-	-
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	-	900K	-879K	-	-
Foreign Exchange Rate Adjustments	291K	-133K	-553K	375K	-1.97M
Miscellaneous Cash Flow Adjustments	-	-	-	-70K	-
Net Change in Cash	-4.15M	-2.89M	-366K	-831K	-501K
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Levered Free Cash Flow	-2.64M	-2.43M	59.25K	-546K	13.54M
Unlevered Free Cash Flow	-2.63M	-2.41M	62.38K	-546K	13.55M
Change In Net Working Capital	-1.11M	419K	-342K	390K	-779K
Net Debt Issued / Repaid	-	900K	-879K	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-21.67	-20.51	-8.24	-5.08	-33.01
Return on Total Capital	-22.9	-23.54	-10.47	-6.82	-54.97
Return On Equity %	-32.81	-53.28	-100.71	-0.13	-94.51
Return on Common Equity	-32.81	-53.28	-100.71	-0.13	-94.51
Short Term Liquidity
Current Ratio	5.24	2.81	3.59	4.47	1.6
Quick Ratio	5.17	2.79	3.58	4.32	1.6
Operating Cash Flow to Current Liabilities	-3.26	-2.92	1.15	-1.91	-9.33
Long Term Solvency
Total Debt/Equity	-	-	-	-	-
Total Debt / Total Capital	-	-	-	-	-
Total Liabilities / Total Assets	9.08	18.82	27.88	22.38	62.41
EBIT / Interest Expense	-279.05	-101.72	-169.8	-	-208.17
EBITDA / Interest Expense	-275.05	-92.74	-109.8	-	-
(EBITDA - Capex) / Interest Expense	-275.71	-92.74	-109.8	-	-
Total Debt / EBITDA	-	-	-	-	-
Net Debt / EBITDA	1.14	1.02	6.08	-49.14	-
Total Debt / (EBITDA - Capex)	-	-	-	-	-
Net Debt / (EBITDA - Capex)	1.14	1.02	6.08	-49.14	-
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	170.67	-37.38	-84.02	-109.29	-
EBITA, 1 Yr. Growth %	170.6	-37.32	-84.05	-54.64	401.61
EBIT, 1 Yr. Growth %	165.76	-32.3	-78.6	-70.67	401.61
Earnings From Cont. Operations, 1 Yr. Growth %	126.36	6.96	-9.05	-99.94	44.63K
Net Income, 1 Yr. Growth %	134.38	2.5	-16.22	-84.13	-198.46
Normalized Net Income, 1 Yr. Growth %	131.72	0.63	-84.7	-99.63	44.63K
Diluted EPS Before Extra, 1 Yr. Growth %	129.75	6.96	-9.02	-99.94	41.35K
Inventory, 1 Yr. Growth %	-65.06	-54.26	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	157.14	-100	-	-	-
Total Assets, 1 Yr. Growth %	-22.41	-36.33	-63.13	-23.47	-21.82
Tangible Book Value, 1 Yr. Growth %	-39.34	-61.81	-22.06	-17.63	-62.14
Common Equity, 1 Yr. Growth %	-27.61	-43.15	-67.24	-17.63	-62.14
Cash From Operations, 1 Yr. Growth %	107.3	18.01	-121.59	-201.88	274.29
Capital Expenditures, 1 Yr. Growth %	40	-	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	96.83	-8.09	-102.44	-1.02K	-2.58K
Unlevered Free Cash Flow, 1 Yr. Growth %	97.32	-8.56	-102.59	-974.75	-2.58K
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	60.54	30.19	-69.17	-87.82	-
EBITA, 2 Yr. CAGR %	60.53	30.24	-69.18	-73.1	50.83
EBIT, 2 Yr. CAGR %	59.1	34.13	-61.94	-74.95	21.29
Earnings From Cont. Operations, 2 Yr. CAGR %	66.09	55.6	-1.37	-97.69	-48.72
Net Income, 2 Yr. CAGR %	86.8	55	-7.33	-63.54	-11.82
Normalized Net Income, 2 Yr. CAGR %	104.91	52.7	-60.76	-97.62	28.88
Diluted EPS Before Extra, 2 Yr. CAGR %	87.47	56.76	-1.35	-97.69	-50.71
Inventory, 2 Yr. CAGR %	-31.95	-60.02	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	144.95	-	-	-	-
Total Assets, 2 Yr. CAGR %	-21.98	-29.71	-51.55	-46.88	-22.65
Tangible Book Value, 2 Yr. CAGR %	-30.04	-51.87	-45.44	-19.88	-44.15
Common Equity, 2 Yr. CAGR %	-22.47	-35.85	-56.85	-48.06	-44.15
Cash From Operations, 2 Yr. CAGR %	42.01	56.4	-49.52	-53.1	229.18
Levered Free Cash Flow, 2 Yr. CAGR %	18.61	34.5	-85.03	-52.61	1.41K
Unlevered Free Cash Flow, 2 Yr. CAGR %	18.77	34.32	-84.6	-52.37	1.37K
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	43.69	17.3	-36.4	-79.33	-
EBITA, 3 Yr. CAGR %	43.67	17.33	-36.42	-64.94	-28.67
EBIT, 3 Yr. CAGR %	44.33	19.67	-27.25	-65.1	-31.97
Earnings From Cont. Operations, 3 Yr. CAGR %	38.01	43.43	30.1	-91.7	-37.93
Net Income, 3 Yr. CAGR %	32.46	52.93	26.26	-48.54	-13.31
Normalized Net Income, 3 Yr. CAGR %	66.66	61.67	-29.07	-91.7	-36.66
Diluted EPS Before Extra, 3 Yr. CAGR %	46.17	55.48	30.76	-91.71	-39.55
Inventory, 3 Yr. CAGR %	-19.32	-40.39	-	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	81.71	-	-	-	-
Total Assets, 3 Yr. CAGR %	-12.17	-27.09	-43.31	-43.57	-39.57
Tangible Book Value, 3 Yr. CAGR %	-14.65	-42.82	-43.48	-37.41	-37.59
Common Equity, 3 Yr. CAGR %	-10.07	-30.09	-48.72	-46.47	-53.25
Cash From Operations, 3 Yr. CAGR %	15.53	33.51	-19.17	-36.21	32.76
Levered Free Cash Flow, 3 Yr. CAGR %	43.14	8.94	-64.67	-40.9	77.31
Unlevered Free Cash Flow, 3 Yr. CAGR %	43.24	8.85	-63.97	-40.8	77.92
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	27.14	37.87	-22.37	-53.07	-
EBITA, 5 Yr. CAGR %	26.52	37.88	-22.38	-35.57	-10.18
EBIT, 5 Yr. CAGR %	26.87	40.41	-15.31	-35.98	-10.75
Earnings From Cont. Operations, 5 Yr. CAGR %	40.48	88.95	20.66	-72.49	-10.35
Net Income, 5 Yr. CAGR %	41.68	71.25	14.82	-13.82	9.37
Normalized Net Income, 5 Yr. CAGR %	34.59	94.64	-6.54	-70.07	-9.93
Diluted EPS Before Extra, 5 Yr. CAGR %	40.38	88.38	24.89	-71.14	-11.5
Inventory, 5 Yr. CAGR %	10.91	-	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	-58.8	-	-	-	-
Total Assets, 5 Yr. CAGR %	-9.01	-15.97	-30.77	-35.76	-35.81
Tangible Book Value, 5 Yr. CAGR %	-18.57	-32.2	-28.64	-34.56	-43.75
Common Equity, 5 Yr. CAGR %	-10.56	-19.37	-32.96	-37.92	-46.94
Cash From Operations, 5 Yr. CAGR %	61.85	41.17	-17.04	-12.14	41.75
Capital Expenditures, 5 Yr. CAGR %	69.52	-	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	43.51	9.1	-41.98	-21.91	58.76
Unlevered Free Cash Flow, 5 Yr. CAGR %	43.83	8.96	-41.3	-21.79	59